The grant of supplementary protection certificates (SPCs) has been the subject of numerous recent cases in Europe. In the UK, the latest development in Neurim Pharmaceuticals (1991) Limited v.…
On the basis of a use patent, Aventis filed for interim relief against Hospira at the Bailiff’s Court (Enforcement court) at Lyngby City Court in Denmark. The claim was based on DK/EP 0593656 and…
I have to start this with a simple introduction into container technology:
This is an intermediate bulk container (IBC):
In principle such an IBC consists of three elements, the base, the…
One of the new question marks introduced by Directive 2004/48 (the so-called "Enforcement Directive") is what amount of indicia is required to prove that an act of infringement is "imminent" for the…
The questions referred to the Enlarged Board of Appeal were answered as follows:
1. A claimed imaging method, in which, when carried out, maintaining the life and health of the subject is important…
In the case at hand the Board held that the European Patent Convention does not contain any specific provision for refusing a European patent application for unallowable double patenting. According…
George Washington once speculated whether it could be said that an axe which had received three new handles and two new heads could be said to be the original axe. Whilst not providing the answer to…
On 18 June 2009 the IP Chamber of the Milan Court issued its official interpretation on whether the filing of an MA application for a generic drug when the patent is still in force results an act of…
There have been some interesting developments lately on the international IP piracy front relating to the so-called manufacturing fiction and the Anti-Counterfeiting Trade Agreement (ACTA). These…
During the past 9 months in Denmark, the pharmaceuticals manufacturer and patentee, H. Lundbeck A/S, has obtained two interlocutory injunctions in Denmark against wholesalers marketing generic…
